NLRP3 and pulmonary fibrosis: Furthermore, our findings demonstrated that NecroX-5 ameliorated BLM-induced pulmonary fibrosis by inhibiting the TGF-β1/Smad2/3-mediated EMT process, which is dependent on the inhibition of NLRP3 inflammasomes.